Bedfont Scientific announced today that it received FDA clearance for its NObreath FeNO airway inflammation monitor. Maidstone, England-based Bedfont designed its NObreath fractional exhaled nitric oxide (FeNO) monitoring system as a portable, non-invasive device for measuring FeNO in the human breath. Inflammatory conditions like asthma can often increase production of nitric oxide. According to a […]
bedfont
Bedfont wins FDA nod for ToxCO carbon monoxide monitor
British medical device firm Bedfont said today that it won FDA 510(k) clearance for its ToxCO breath analysis monitor designed to measure exhaled carbon monoxide to indicate levels of CO in the blood. The newly cleared system is intended for use in triaging cases of CO poisoning as it provides instant results at the point-of-care, […]